Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel

Rinat Cohen-Moreno, Miriam Schiff, Shabtay Levitt, Rachel Bar-Hamburger, Shiela Strauss, Yehuda Neumark

Research output: Contribution to journalArticle

Abstract

Ignorance about Hepatitis-C (HCV) among drug users, treatment staff, and policy makers thwarts treatment uptake and facilitates virus transmission. We assessed knowledge about HCV among methadone patients in Israel, where effective HCV-treatment is provided at low-cost within the national health insurance framework, yet few infected methadone patients are treated. In 2006, 512 patients in two methadone clinics in Israel were interviewed, of whom 53% were HCV-positive. The clinics were purposively selected from the 11 methadone clinics in the country. Respondents exhibited poor knowledge about HCV, particularly about diagnosis and treatment. Lesser-educated respondents were three times more likely to score low on HCV-knowledge compared to those with 12+ years of schooling (AOR = 2.97, 95 CI = 1.55.7. HCV-negative patients were also three-times more likely than HCV-positive patients to score low on the HCV-knowledge scale (Adjusted Odds Ratio = 3.0, 95% Confidence Interval = 1.94.7). Enhancing HCV-knowledge may help patients avoid becoming infected and infecting others, allay exaggerated fears about hepatitis, and facilitate HCV-treatment initiation among those infected.

Original languageEnglish (US)
Pages (from-to)58-76
Number of pages19
JournalSubstance Use and Misuse
Volume45
Issue number1-2
DOIs
StatePublished - 2010

Fingerprint

Methadone
Israel
Hepatitis C
contagious disease
health insurance
confidence
anxiety
drug
staff
Therapeutics
costs
National Health Programs
Drug Users
Administrative Personnel
Hepatitis
Fear
Odds Ratio
Confidence Intervals
Viruses
Costs and Cost Analysis

Keywords

  • Drug dependence
  • HCV
  • Hepatitis C
  • Knowledge
  • Methadone

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Medicine (miscellaneous)

Cite this

Cohen-Moreno, R., Schiff, M., Levitt, S., Bar-Hamburger, R., Strauss, S., & Neumark, Y. (2010). Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel. Substance Use and Misuse, 45(1-2), 58-76. https://doi.org/10.3109/10826080902864894

Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel. / Cohen-Moreno, Rinat; Schiff, Miriam; Levitt, Shabtay; Bar-Hamburger, Rachel; Strauss, Shiela; Neumark, Yehuda.

In: Substance Use and Misuse, Vol. 45, No. 1-2, 2010, p. 58-76.

Research output: Contribution to journalArticle

Cohen-Moreno, R, Schiff, M, Levitt, S, Bar-Hamburger, R, Strauss, S & Neumark, Y 2010, 'Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel', Substance Use and Misuse, vol. 45, no. 1-2, pp. 58-76. https://doi.org/10.3109/10826080902864894
Cohen-Moreno, Rinat ; Schiff, Miriam ; Levitt, Shabtay ; Bar-Hamburger, Rachel ; Strauss, Shiela ; Neumark, Yehuda. / Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel. In: Substance Use and Misuse. 2010 ; Vol. 45, No. 1-2. pp. 58-76.
@article{d01fece68fc94c1881d2a7c40adf5f7c,
title = "Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel",
abstract = "Ignorance about Hepatitis-C (HCV) among drug users, treatment staff, and policy makers thwarts treatment uptake and facilitates virus transmission. We assessed knowledge about HCV among methadone patients in Israel, where effective HCV-treatment is provided at low-cost within the national health insurance framework, yet few infected methadone patients are treated. In 2006, 512 patients in two methadone clinics in Israel were interviewed, of whom 53{\%} were HCV-positive. The clinics were purposively selected from the 11 methadone clinics in the country. Respondents exhibited poor knowledge about HCV, particularly about diagnosis and treatment. Lesser-educated respondents were three times more likely to score low on HCV-knowledge compared to those with 12+ years of schooling (AOR = 2.97, 95 CI = 1.55.7. HCV-negative patients were also three-times more likely than HCV-positive patients to score low on the HCV-knowledge scale (Adjusted Odds Ratio = 3.0, 95{\%} Confidence Interval = 1.94.7). Enhancing HCV-knowledge may help patients avoid becoming infected and infecting others, allay exaggerated fears about hepatitis, and facilitate HCV-treatment initiation among those infected.",
keywords = "Drug dependence, HCV, Hepatitis C, Knowledge, Methadone",
author = "Rinat Cohen-Moreno and Miriam Schiff and Shabtay Levitt and Rachel Bar-Hamburger and Shiela Strauss and Yehuda Neumark",
year = "2010",
doi = "10.3109/10826080902864894",
language = "English (US)",
volume = "45",
pages = "58--76",
journal = "Substance Use and Misuse",
issn = "1082-6084",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel

AU - Cohen-Moreno, Rinat

AU - Schiff, Miriam

AU - Levitt, Shabtay

AU - Bar-Hamburger, Rachel

AU - Strauss, Shiela

AU - Neumark, Yehuda

PY - 2010

Y1 - 2010

N2 - Ignorance about Hepatitis-C (HCV) among drug users, treatment staff, and policy makers thwarts treatment uptake and facilitates virus transmission. We assessed knowledge about HCV among methadone patients in Israel, where effective HCV-treatment is provided at low-cost within the national health insurance framework, yet few infected methadone patients are treated. In 2006, 512 patients in two methadone clinics in Israel were interviewed, of whom 53% were HCV-positive. The clinics were purposively selected from the 11 methadone clinics in the country. Respondents exhibited poor knowledge about HCV, particularly about diagnosis and treatment. Lesser-educated respondents were three times more likely to score low on HCV-knowledge compared to those with 12+ years of schooling (AOR = 2.97, 95 CI = 1.55.7. HCV-negative patients were also three-times more likely than HCV-positive patients to score low on the HCV-knowledge scale (Adjusted Odds Ratio = 3.0, 95% Confidence Interval = 1.94.7). Enhancing HCV-knowledge may help patients avoid becoming infected and infecting others, allay exaggerated fears about hepatitis, and facilitate HCV-treatment initiation among those infected.

AB - Ignorance about Hepatitis-C (HCV) among drug users, treatment staff, and policy makers thwarts treatment uptake and facilitates virus transmission. We assessed knowledge about HCV among methadone patients in Israel, where effective HCV-treatment is provided at low-cost within the national health insurance framework, yet few infected methadone patients are treated. In 2006, 512 patients in two methadone clinics in Israel were interviewed, of whom 53% were HCV-positive. The clinics were purposively selected from the 11 methadone clinics in the country. Respondents exhibited poor knowledge about HCV, particularly about diagnosis and treatment. Lesser-educated respondents were three times more likely to score low on HCV-knowledge compared to those with 12+ years of schooling (AOR = 2.97, 95 CI = 1.55.7. HCV-negative patients were also three-times more likely than HCV-positive patients to score low on the HCV-knowledge scale (Adjusted Odds Ratio = 3.0, 95% Confidence Interval = 1.94.7). Enhancing HCV-knowledge may help patients avoid becoming infected and infecting others, allay exaggerated fears about hepatitis, and facilitate HCV-treatment initiation among those infected.

KW - Drug dependence

KW - HCV

KW - Hepatitis C

KW - Knowledge

KW - Methadone

UR - http://www.scopus.com/inward/record.url?scp=73649131591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649131591&partnerID=8YFLogxK

U2 - 10.3109/10826080902864894

DO - 10.3109/10826080902864894

M3 - Article

VL - 45

SP - 58

EP - 76

JO - Substance Use and Misuse

JF - Substance Use and Misuse

SN - 1082-6084

IS - 1-2

ER -